DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹487 Cr | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr |
What is the latest Consolidated Net Profit of DR LAL PATHLABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹487 Cr |
| Mar2025 | ₹358 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹345 Cr |
| Mar2022 | ₹292 Cr |
How is Consolidated Net Profit of DR LAL PATHLABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹487 Cr | 36.17 | |
| Mar2025 | ₹358 Cr | 49.78 | |
| Mar2024 | ₹239 Cr | -30.74 | |
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | - | |
Compare Consolidated Net Profit of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹27,589.5 Cr | -0.1% | 4.9% | 20.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,930.0 Cr | 2.8% | 7.4% | 22.5% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹112,230.0 Cr | 0.2% | 19.4% | -11% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹73,585.8 Cr | 2.4% | 4.8% | 23.3% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹41,071.4 Cr | 3.5% | 8.7% | 32.5% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹40,911.0 Cr | 5.2% | 1% | -4.1% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -0.1% |
4.9% |
20.1% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses